Venofer®Iron Sucrose Injection, USP (20 mg/mL), 10 mL Single-Dose Vial (5 Pack)

Venofer®Iron Sucrose Injection, USP (20 mg/mL), 10 mL Single-Dose Vial (5 Pack)

Pack (5 x 10mL Vials / Each)

Venofer® (Iron Sucrose Injection, USP) (Product #00517231005 / NDC 00517-2310-05) manufactured by American Regent, Inc. is a sterile, clear, dark brown, nonpyrogenic aqueous complex of ferric hydroxide in sucrose for intravenous use. Each milliliter contains 20 mg of elemental iron as iron sucrose. Supplied in a box of 5 single-dose vials (10 mL per vial / 200 mg elemental iron per vial), this branded parenteral iron replacement agent is indicated for the treatment of iron deficiency anemia (IDA) in adult and pediatric patients (1 year of age and older) with chronic kidney disease (CKD).

Add to Order Guide
Add to Order Guide

SKU: AME 00517231005

Product Specifications

Specification Details
Manufacturer / Brand American Regent, Inc. / Venofer®
Manufacturer SKU / Item # 00517231005
NDC Number 00517-2310-05 (Box) / 00517-2310-01 (Vial)
Active Ingredient Iron Sucrose (Ferric Hydroxide-Sucrose Complex)
Elemental Iron Content 20 mg/mL (200 mg elemental iron per 10 mL vial)
Total Content per Vial 200 mg Elemental Iron / 10 mL
Volume per Unit 10 mL
Container Type Glass Single-Dose Vial (SDV)
Administration Route Intravenous (IV) Slow Injection or IV Infusion
Formulation Preservative-Free / Aqueous Solution / pH 10.5 to 11.1
Storage Temperature 20°C to 25°C (68°F to 77°F) (Do not freeze)
Packaging Configuration 5 Vials per Box / Pack
Regulatory Category Prescription-Only (Rx)
HCPCS Code

Key Features & Clinical Applications

  • Targeted Anemia Management in CKD: Indicated for iron deficiency anemia in non-dialysis dependent (NDD-CKD), hemodialysis dependent (HDD-CKD), and peritoneal dialysis dependent (PDD-CKD) patients.

  • Higher Dose Capacity: The 10 mL (200 mg) vial is structured for clinical protocols requiring higher single-dose iron administration, such as non-dialysis dependent CKD regimen dosing.

  • Preservative-Free Formulation: Formulated without added preservatives or benzyl alcohol for safe IV administration.

  • Lower Anaphylaxis Risk: Demonstrates a lower risk of severe hypersensitivity reactions compared to traditional high-molecular weight iron dextrans and does not require a test dose.

  • Flexible IV Delivery: Can be administered undiluted via slow IV injection or diluted in 0.9% Sodium Chloride Injection for IV infusion.

⚠️ Hypersensitivity Warning: Serious systemic hypersensitivity reactions, including anaphylactic-type reactions, may occur. Administer under clinical supervision with emergency resuscitation equipment available.

⚠️ Administration Guidelines: Do not give as a rapid IV push. Administer 200 mg doses either as an undiluted slow IV injection over at least 2 to 5 minutes or as an infusion diluted in 0.9% Sodium Chloride over at least 15 to 30 minutes.

⚠️ Iron Overload Precaution: Regularly monitor serum ferritin, hemoglobin, and transferrin saturation to avoid iron overload.

Unit of Measure

Pack (5/EA)

You may also like…

Scroll to Top